SlideShare une entreprise Scribd logo
1  sur  60
Télécharger pour lire hors ligne
Pigmented
lesion of oral mucosa
DR PRIYANKA
SENIOR LECTURER
ORAL MEDICINE AND RADIOLOGY
contents
• Introduction
• Classification of pigmented lesions
• Endogenous pigmentation
 Focal pigmented lesion
 Diffuse pigmented lesion
 Melanosis associated with systemic or genetic disease
• Exogenous pigmentation
• Conclusion
Introduction
• Healthy oral mucous membrane
normally has various shades of pink
• The color of oral mucosa can be
attributed to vascular supply, thickness
and degree of keratinization of the
epithelium and presence of pigment
containing cells
• In many instances, oral mucosa may
show pigmentation
• Melanin, a non haemoglobin derived brown pigment, normally present in the oral mucosa
Functions of oral melanocytes
• Color- determine color of mucosa
• Protection – from stressor UV radiation, free radicals
• Neutralise bacteria derived enzymes and toxins
• Act as antigen presenting cell, can stimulate T cell proliferation, can phagocyte
microorganism
PIGMENTED LESIONS OF ORAL
MUCOSA
• Oral and Perioral pigmentation may be
physiologic (or) pathologic in origin.
• Variety of discolorations - brown, blue,
grey & black.
• These color changes often occur due to
deposition, production (or) increased
accumulation of various endogenous (or)
exogenous pigmented substances.
CLASSIFICATION
ENDOGENOUS PIGMENTATION
FOCAL MELANOCYTIC PIGMENTATION
• Freckle / Ephelis
• Oral / labial melanotic macule
• Oral melanoacanthoma
• Melanocytic nevus
• Malignant melanoma
MULTIFOCAL / DIFFUSE PIGMENTATION
• Physiologic pigmentation
• Drug induced melanosis
• Smoker melanosis
• Post inflammatory hyper pigmentation
• Melasma (chlosma)
MELANOSIS ASSOCIATED WITH SYSTEMIC (OR)GENETIC DISEASE
• Hypoadrenocorticism (addison’s disease)
• Cushing’s syndrome.
• Hyperthyrodism (graves disease)
• Primary biliary cirrhosis
• Vitamin B12 deficiency
• Peutz jeghers syndrome
• HIV / AIDS associated melanosis
IDIOPATHIC PIGMENTATION
• Laugier – hunziker pigmentation
DEPIGMENTATION
• Vitiligo
HAEMOGLOBIN & IRON ASSOCIATED PIGMENTATION
• Ecchymosis
• Purpura / Petechiae
• Hemochromatosis
Classification
Dr. Reshna Roy. Classification of oral pigmented
lesions: A review .International Journal of
Applied Dental Sciences 2019; 5(2): 397-402
MISCELLANOUS LESIONS THAT MAY BE ASSOCIATED
WITH ORAL MUCOSAL DISCOLORATION
Investigations
• Biopsy
• Diascopy
• Radiography
• Blood tests
Focal melanocytic pigmentation
Freckle / ephelis
• commonly occuring, asymptomatic ,
small (1–3mm), well circumsribed , tan
or brown colored macule
• SITE- sun exposed regions of facial &
perioral skin.
• ETIOLOGY- overproduction of direct
melanocyte
• Polymorphisms in MC1R gene is
strongly associated with development
of childhood freckles.
Oral / labial melanotic macule
• Etiology – trauma (Increase in melanin
synthesis by melanocytes without an increase
in the number of melanocytes)
• GENDER- females, any age
• SITE- lower lip & gingiva.
• Clinical features- Melanotic macules tend to
be small (<1cm), well circumscribed , oval or
irregular in outline & often uniformly
pigmented.
Oral melanoacanthoma
• Etiology - acute trauma or a history of chronic
irritation
• Proliferation of dendritic melanocyte scattered
throughout thickness of an acanthotic and
hyperkeratotic surface epithelium
• Features- Rapidly enlarging , ill defined , macular or
plaque like lesion, Dark brown to black, flat or raised
• Site- Buccal mucosa most common site of occurrence
• Treatment is source of irritation should be removed
Melanocytic nevus
• Etiology
 Effect of sun exposure recognized in development of
cutaneous nevi.
 Recent study shows dermal melanocytic nevi exhibit somatic
activating mutations in BRAF oncogene.
• Features- asymptomatic, small (1cm) , solitary , brown or
blue , well circumscribed nodule or macule.
• Site - Oral nevi present in hard palate is the most common
site , followed by buccal & labial mucosa & gingiva.
• Treatment - complete but conservative surgical excision.
• Rare recurrence
Malignant melanoma
• Etiology
 Episodes of acute sun exposure , especially at young age
 Immunosuppresion
 Exhibit mutation in the BRAF , HRAS & NRAS proto oncogenes.
• Site- Palate represents most common site & next comes the maxillary
gingiva.
• Features- macular , plague like or mass forming , well circumscribed,
irregular & exhibit focal or diffuse areas of brown , blue or black
pigmentation.
• Radial growth phase and vertical growth phase
• ABCDE of melanoma
 A- asymmetry
 B- border irregular
 C- color irregularity
 D- diameter >6mm
 E- evolving over time
Malignant melanoma
• Types –
• 1. superficial spreading melanoma (65%)
• 2. nodular melanoma (13%)
• 3. lentigo maligna melanoma (10%)
• 4. acral lentiginous melanomas (10%)
• 5. mucosal lentiginous melanomas (3%)
• Treatment is ablative surgery with wide margins .
• Adjuvant radiotherapy is necessary.
• Recent development is antitumor vaccine adjuvant
interferon alpha – 2B therapy is used to treat primary
cutaneous melanomas >2mm in thickness.
Multifocal / diffuse pigmentation
Physiologic pigmentation
• More common
• Mostly occur in gingiva
• Treatment is gingivectomy
& laser therapy have been
used to remove pigmented
oral mucosa.
• Effects of treatment is
temporary & may eventually
recur.
Drug induced melanosis
• Chief drugs include
a) Minocycline – tetracycline derivative
b) Antimalarials include chloroquine, quinacrine
hydroxychloroquine,
c) Phenothiazines such as chlorpromazine
d) Oral contraceptives
e) Cytotoxic medications such as cyclophosphamide
• Clinically the pigment can be diffuse yet localised to one
mucosal surface , often hard palate
• Lesions are flat & without any evidence of nodularity or
swelling.
• Diagnosis & treatment is discoloration tends to fade within a
few months after the drug is discontinued.
Smokers melanosis
• Features- Diffuse melanosis of anterior facial
maxillary & mandibular gingivae , buccal mucosa
, lateral tongue , palate & floor of mouth
• Pigmented areas are brown , flat & irregular.
• Etiology- Melanin synthesis is stimulated by
tobacco smoke products.
• Heat of smoke may stimulate pigmentation.
Post inflammatory pigmentation
• Focal or diffuse pigmentation
in areas that were subjected to
previous injury or
inflammation.
• The mucosa overlying a non
melanocytic malignancy may
become pigmented.
Melasma / chloasma
• Acquired symmetric melanosis
that typically develops on sun
exposed areas of skin &
frequently on face.
• Forehead, cheeks, upper lips &
chin are most commonly affected
areas.
• Melasma has been used to
describe any form of generalised
facial hyperpigmentation
including those related to post
inflammatory changes &
medication use.
Melanosis associated
with systemic or genetic
disease
Hypoadrenocorticism
• As steroid levels decrease , there is a
compensatory activity by ACTH
secretion , but if persists , the serum
levels of alpha melanocyte stimulating
hormone also increase.
• Mucocutaneous hyperpigmentation
• Generalised bronzing of skin & diffuse
but patchy melanosis of oral mucosa.
• Treatment is exogenous steroid
replacement therapy.
Cushing's syndrome
• Prolonged exposure of endogenous
or exogenous corticosteroids.
• Due to activating , germline
mutations in ACTH receptor.
• Weight gain & characterstic “moon
facies”.
• Diffuse mucocutaneous
pigmentation.
• Treatment is surgical , radiation or
medicinal therapy
Hyperthyroidism
• 40% of black patients with
thyrotoxicosis may present
mucocutaneous pigmentation.
• Pigmentation tends to resolve
following treatment of
thyroid abnormality.
• Melasma
• Intolrence to heat, bulging of
eye, facial flushing, enlarged
thyroid, clubbing
Primary biliary cirrhosis
• Autoimmune
• Develops in middle aged women.
• Disease results from damage to small
intra hepatic bile ducts.
• Oral mucosal tissues are not affected
• Elevated serum copper level lead to
tyrosinase reaction and increase
melanin synthesis
Vitamin B12
deficiency
• Generalised burning
sensation & erythema &
atrophy of the mucosal
tissue.
• Pigmentation resolves
following vitamin B12
levels.
Peutz – jeghers syndrome
• Etiology- Autosomal dominant disease
associated with mutations in
STK11/LKB1 tumor suppressor gene.
• Features- Intestinal polyposis, cancer
predisposition & multiple, small,
pigmented macules of lip , perioral skin ,
hand & feet.
• Resemble ephelies usually <0.5mm in
diameter.
• Lesion may develop on anterior tongue ,
buccal & labial mucosa.
• Lip & perioral pigmentation is highly
distinctive
Café –au – lait pigmentation
• Identified in number of different genetic
disorders include
a) Neuro fibromatous type .
b) Mccune– albright syndrome
c) Noonans syndrome
• Features - Present as tan or brown colored ,
irregularly shaped macules of variable size.
• Occur anywhere on skin , oral macular
pigmentation have been reported.
• Well circumscribed, pigmented macule or
patch , few mm to cms, appear at birth or early
life
HIV / AIDS
• Pigmentation may be related to
intake of various medications -
anti fungal & anti retroviral drugs.
• May also occur due to adreno
cortical destruction by virulent
infectious organisms.
• Significant correlation between
mucocutaneous pigment & CD4
counts / mili litre less than or equal
to 200.
• Site- Buccal mucosa is most
affected site ,gingiva , palate
&tongue involved
Idiopathic pigmentation
• LAUGIER – HUNZIKER
PIGMENTATION:
• Hyperpigmentation of oral mucosal
tissues involve lips & buccal mucosa.
• Pigmentation of esophageal , genital &
conjunctival mucosae & acral surfaces.
• Nail involvement in form of longitudinal
melanotic streaks & without evidence of
dystrophic change.
• Multiple , discrete , irregularly shaped
brown oral macules & not more than
3mm in diameter
Treatment of mucocutaneous melanosis
• Laser therapy has proven effective but recurrence occur in 20% of treated patients.
• Cryotherapy
• Phototherapy include intense pulsed light & fractional photothermolysis.
• First- line therapy involves application of topical medicaments , that is bleaching cream.
• Simple agents such as azelaic acid or hydroquinone.
• Triple combination therapy
a. 4% hydroquinone
b. 0.05% retinoic acid
c. 0.01% fluocinolone acetonide has proven effective in 90% of patients.
Depigmentation
• VITILIGO :
• Relatively common , acquired autoimmune disease that is associated with hypomelanosis.
• Focal areas of depigmentation
• Vitiligenous lesion often present as well –circumscribed , round , oval ,or elongated pale
or white colored macules that may coalesce into larger areas of diffuse pigmentation.
• Arise in any patients undergoing immunotherapy
• Hypomelanosis of inner & outer surfaces of lips & perioral skin may be seen in up to 20%
of patients.
• Treatment with topical corticosteroids , systemic photochemical therapies (psoralen &
ultraviolet A exposure proven effective.
• Medicinal depigmentation that is cutaneous bleaching to create unified skin color.
• Surgical intervention may be only optional (autologous epithelial grafts) used succesfully
HEMOGLOBIN AND IRON
ASSOCIATED PIGMENTATION
Ecchymosis
• Traumatic ecchymosis is common on the lips
and face yet is uncommon in oral mucosa
except in cases of blunt force trauma and oral
intubation.
• Immediately following traumatic event
erythrocyte extravasation into the sub mucosa
will appear as bright red macule.
• The lesion will assume brown coloration within
few days, after hemoglobin is degraded to
hemosiderin.
PURPURA/PETECHIAE
• Petechiae typically characterised as
being pinpoint or slightly larger than
pinpoint and purpura as multiple,
small 0 to 2 mm collections of
extravasated blood.
• Oral purpura may develop as a
consequence of trauma or viral or
systemic disease, identified in soft
palate although any mucosal site may
be affected.
HEMOCHROMATOSIS
• Chronic, progressive disease that is characterized by excessive iron deposits (usually in the
form of hemosiderin) in the liver and other organs and tissues.
• Oral mucosal pigmentation is also well reorganized.
• Oral pigmentation is often diffuse and brown to gray in appearance.
• Palate and gingiva are most commonly affected.
EXOGENOUS PIGMENTATION
AMALGAM TATTO:
• Etiology is deposition of amalgam
material into submucosal tissue.
• Lesions small, asymptomatic, macular
and bluish gray or oven black in
appearance.
• Gingiva, alveolar mucosa, buccal mucosa
and floor of mouth are most common
sites.
• Lesions found in vicinity of teeth with
large amalgam restoration or crowned
teeth and also in around healed extraction
sites.
GRAPHITE TATTOO
• Site- Commonly seen on palate
• Etiology- Represent traumatic implantation
of graphite particles from a pencil
• Feature- Lesion present similar to amalgam
tattoo. Diffuse macular lesion
• So biopsy is often warranted.
ORNAMENTAL TATTOOS
• South African female tribal custom
includes brushing the teeth and gums
with a chewed root of the tree with the
belief that promotes oral health.
• Plant root contain napthoquinones are
pigmented and the mouths of root users
are typically bright orange.
MEDICINAL METAL
INDUCED
PIGMENTATION
• Silver may cause generalized blue-
gray discoloration (argyria).
• Gold induced pigment may appear
blue-gray or purple (chrysiasis).
• Generalized black pigmentation of
tongue due to chewing of bismuth
sub salicylate tablets, a commonly
used antacid.
HEAVY METAL PIGMENTATION
• Lead, mercury, bismuth and arsenic have shown
to be deposited in oral tissue if ingested in
sufficient quantities over a extended period of
time.
• Found along the free marginal gingiva, metallic
line usually gray-black appearance.
• Signs and symptoms of metal poisoning-
neurologic disorders, intestinal pain and
sialorrhea.
HAIRY TONGUE
• Change in oral flora associated with chronic
antibiotic therapy.
• Colonization of chromogenic bacteria impart
variety of colors white, green, brown or black.
• Various foods, drinks and also smoking of
tobacco or crack cocaine has been shown in
black hairy tongue.
• Treatment is using tongue scrapper and limit
ingestion of coloring foods.
HEMANGIOMA
• Lesions presenting as proliferation of endothelial cells that line vascular channels
• Arise in childhood, adults
• Child- skin, scalp, within connective tissue of mucous membrane
• Approx 85% of childhood, onset spontaneous regress after puberty
• Appear as reddish blue or deep blue
• Mostly are raised and nodular, some may be flat, macular, diffuse, particularly on facial
skin – port wine stain
• Oral hemangioma- tongue, lip
• Concurrent history of seizures,
• RADIOGRAPH – vessel wall calcifications – TRAM LINE CALCIFICATIONS
• Honey comb trabeculated appearance
• Overlying cortex is expanded and thinned but complete cortical disruption and invasion
into soft tissue are not present
• TREATMENT-
• Sclerosing agent- 1% sodium tetradecyl sulfate (intrlesional)- 0.05- 0.15ml/cm3
• Laser, cryosurgery
VARIX
• Pathologic dilatations of veins or venules are varices or varicosities
• Site- ventral tongue- tortuous ,serpentine blue, red, and purple elevations
• Progressively prominent with age
• painless & non haemorrhagic
• No interference with mastication
ANGIOSARCOMA
 Malignant vascular neoplasm.
 Arise anywhere in body- head and neck, breast and extremities,
 Male , any age
 Colour: red ,blue or purple .
 Very aggressive and rare type of soft tissue sarcomas
 can arise from blood or lymph vessel endothelial cells / pericytic cells of vasculature.
 Treated by radical excision
KAPOSI SARCOMA
• Tumor of endothelial cell origin
• HHV-8
• 2 forms- elderly men ( oral mucosa & skin of lower extremities) ,
children in equatorial africa ( lymph nodes)-aggressive & lethal
• Slow progressive, less metastasis
• Oral tumors - red, blue, and purple-hard palate, facial gingiva
Differential diagnosis of a case of brownish black pigmentation
Differential diagnosis of a case of blue to purplish pigmentation
How to approach a case of tooth staining
HISTORY
Provides useful information regarding etiology
Includes:
• Dental history (mouthwash, fluoride inatake, oral hygiene practice)
• Medical history (childhood disease, medications)
• Family history (genetic disease- amelogenesis imperfecta)
• Diet history (nutritional deficiency, diet)
• Social history (occupational, use of tobacco)
CLINICAL EXAMINATION
Inspection
• Teeth staining unusual and generalized
• Found on surfaces with poor tooth brush accessibility
• No signs of pulpal involvement
• Intrinsic – either generalized or localized
Scratch test
• Distinguish between intrinsic and extrinsic staining
• Discolored tooth surface scratched
• Intrinsic stains donot get removed
Radiography
• Useful in intrinsic staining (amelogenesis imperfecta, internal resorption)

Contenu connexe

Similaire à Exogenous and endogenous Pigmented lesion of oral cavity

pigmented lesions part 2 .pptx
pigmented lesions part 2 .pptxpigmented lesions part 2 .pptx
pigmented lesions part 2 .pptx
FongChanyip
 

Similaire à Exogenous and endogenous Pigmented lesion of oral cavity (20)

Pigmentations of the oral cavity
Pigmentations  of the oral cavityPigmentations  of the oral cavity
Pigmentations of the oral cavity
 
pigmented lesions part 2 .pptx
pigmented lesions part 2 .pptxpigmented lesions part 2 .pptx
pigmented lesions part 2 .pptx
 
gingival depigmentation part 1-1.pdf
gingival depigmentation part 1-1.pdfgingival depigmentation part 1-1.pdf
gingival depigmentation part 1-1.pdf
 
Oral Pigmentation
Oral PigmentationOral Pigmentation
Oral Pigmentation
 
Printhandler
PrinthandlerPrinthandler
Printhandler
 
PIGMENTATIONS OF ORAL MUCOSA.pptx
PIGMENTATIONS OF ORAL MUCOSA.pptxPIGMENTATIONS OF ORAL MUCOSA.pptx
PIGMENTATIONS OF ORAL MUCOSA.pptx
 
Pigmented lesions of oral cavity (Oral Medicine and Radiology)
Pigmented lesions of oral cavity (Oral Medicine and Radiology)Pigmented lesions of oral cavity (Oral Medicine and Radiology)
Pigmented lesions of oral cavity (Oral Medicine and Radiology)
 
Epithelial Disorders Oral Pathology
Epithelial Disorders Oral PathologyEpithelial Disorders Oral Pathology
Epithelial Disorders Oral Pathology
 
Common oral lesions2
Common oral lesions2Common oral lesions2
Common oral lesions2
 
oral pigmented lesions
oral pigmented lesionsoral pigmented lesions
oral pigmented lesions
 
Oral Pigmentations
Oral PigmentationsOral Pigmentations
Oral Pigmentations
 
Oral precancerous lesions
Oral precancerous lesionsOral precancerous lesions
Oral precancerous lesions
 
oralprecancerouslesions-150430102957-conversion-gate02.pdf
oralprecancerouslesions-150430102957-conversion-gate02.pdforalprecancerouslesions-150430102957-conversion-gate02.pdf
oralprecancerouslesions-150430102957-conversion-gate02.pdf
 
Oral Lichen Planus (OLP)
Oral Lichen Planus (OLP)Oral Lichen Planus (OLP)
Oral Lichen Planus (OLP)
 
Facial melanoses
Facial melanosesFacial melanoses
Facial melanoses
 
Disorders of pigmentation
Disorders of pigmentationDisorders of pigmentation
Disorders of pigmentation
 
Ahmed Al Abbasi/ Oral Cavity and Tongue diseases,
Ahmed Al Abbasi/ Oral Cavity and Tongue diseases,Ahmed Al Abbasi/ Oral Cavity and Tongue diseases,
Ahmed Al Abbasi/ Oral Cavity and Tongue diseases,
 
Vitiligo
VitiligoVitiligo
Vitiligo
 
benign tumors of epithelial origin of oral cavity
benign tumors of epithelial origin of oral cavitybenign tumors of epithelial origin of oral cavity
benign tumors of epithelial origin of oral cavity
 
Precancerous lesions of oral cavity
Precancerous lesions of oral cavityPrecancerous lesions of oral cavity
Precancerous lesions of oral cavity
 

Plus de drpriyanka8

Plus de drpriyanka8 (12)

ORGAN FAILURE AND TRANSPLANTATION MEDICINE
ORGAN FAILURE AND TRANSPLANTATION MEDICINEORGAN FAILURE AND TRANSPLANTATION MEDICINE
ORGAN FAILURE AND TRANSPLANTATION MEDICINE
 
FORENSIC ODONTOLOGY - A NEW DIMENSION IN DENTAL ANALYSIS
FORENSIC ODONTOLOGY - A NEW DIMENSION IN DENTAL ANALYSISFORENSIC ODONTOLOGY - A NEW DIMENSION IN DENTAL ANALYSIS
FORENSIC ODONTOLOGY - A NEW DIMENSION IN DENTAL ANALYSIS
 
RECENT TREATMENT MODALITIES FOR ORAL COMMON MUCOSAL LESIONS.pptx
RECENT TREATMENT MODALITIES FOR ORAL COMMON MUCOSAL LESIONS.pptxRECENT TREATMENT MODALITIES FOR ORAL COMMON MUCOSAL LESIONS.pptx
RECENT TREATMENT MODALITIES FOR ORAL COMMON MUCOSAL LESIONS.pptx
 
Vesiculobullous lesion of oral cavity.pptx
Vesiculobullous lesion of oral cavity.pptxVesiculobullous lesion of oral cavity.pptx
Vesiculobullous lesion of oral cavity.pptx
 
GERIATRIC CARE DENTISTRY - ORAL MANIFESTATIONS IN GERIATRIC PATIENTS
GERIATRIC CARE DENTISTRY - ORAL MANIFESTATIONS IN GERIATRIC PATIENTSGERIATRIC CARE DENTISTRY - ORAL MANIFESTATIONS IN GERIATRIC PATIENTS
GERIATRIC CARE DENTISTRY - ORAL MANIFESTATIONS IN GERIATRIC PATIENTS
 
ORAL MANIFESTATIONS OF ENDOCRINE DISORDERS.ppt
ORAL MANIFESTATIONS OF ENDOCRINE DISORDERS.pptORAL MANIFESTATIONS OF ENDOCRINE DISORDERS.ppt
ORAL MANIFESTATIONS OF ENDOCRINE DISORDERS.ppt
 
RADIATION PHYSICS.pptx
RADIATION PHYSICS.pptxRADIATION PHYSICS.pptx
RADIATION PHYSICS.pptx
 
SALIVA AS A DIAGNOSTIC TOOL.pptx
SALIVA AS A DIAGNOSTIC TOOL.pptxSALIVA AS A DIAGNOSTIC TOOL.pptx
SALIVA AS A DIAGNOSTIC TOOL.pptx
 
RESEARCH METHODOLOGY.pptx
RESEARCH METHODOLOGY.pptxRESEARCH METHODOLOGY.pptx
RESEARCH METHODOLOGY.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
Facial nerve and its applied aspect - seminar 3 [Autosaved].pptx
Facial nerve and its applied aspect - seminar 3 [Autosaved].pptxFacial nerve and its applied aspect - seminar 3 [Autosaved].pptx
Facial nerve and its applied aspect - seminar 3 [Autosaved].pptx
 
CASE HISTORY IN DETAIL
CASE HISTORY IN DETAILCASE HISTORY IN DETAIL
CASE HISTORY IN DETAIL
 

Dernier

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 

Dernier (20)

A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 

Exogenous and endogenous Pigmented lesion of oral cavity

  • 1. Pigmented lesion of oral mucosa DR PRIYANKA SENIOR LECTURER ORAL MEDICINE AND RADIOLOGY
  • 2. contents • Introduction • Classification of pigmented lesions • Endogenous pigmentation  Focal pigmented lesion  Diffuse pigmented lesion  Melanosis associated with systemic or genetic disease • Exogenous pigmentation • Conclusion
  • 3. Introduction • Healthy oral mucous membrane normally has various shades of pink • The color of oral mucosa can be attributed to vascular supply, thickness and degree of keratinization of the epithelium and presence of pigment containing cells • In many instances, oral mucosa may show pigmentation
  • 4. • Melanin, a non haemoglobin derived brown pigment, normally present in the oral mucosa
  • 5. Functions of oral melanocytes • Color- determine color of mucosa • Protection – from stressor UV radiation, free radicals • Neutralise bacteria derived enzymes and toxins • Act as antigen presenting cell, can stimulate T cell proliferation, can phagocyte microorganism
  • 6. PIGMENTED LESIONS OF ORAL MUCOSA • Oral and Perioral pigmentation may be physiologic (or) pathologic in origin. • Variety of discolorations - brown, blue, grey & black. • These color changes often occur due to deposition, production (or) increased accumulation of various endogenous (or) exogenous pigmented substances.
  • 7. CLASSIFICATION ENDOGENOUS PIGMENTATION FOCAL MELANOCYTIC PIGMENTATION • Freckle / Ephelis • Oral / labial melanotic macule • Oral melanoacanthoma • Melanocytic nevus • Malignant melanoma MULTIFOCAL / DIFFUSE PIGMENTATION • Physiologic pigmentation • Drug induced melanosis • Smoker melanosis • Post inflammatory hyper pigmentation • Melasma (chlosma)
  • 8. MELANOSIS ASSOCIATED WITH SYSTEMIC (OR)GENETIC DISEASE • Hypoadrenocorticism (addison’s disease) • Cushing’s syndrome. • Hyperthyrodism (graves disease) • Primary biliary cirrhosis • Vitamin B12 deficiency • Peutz jeghers syndrome • HIV / AIDS associated melanosis IDIOPATHIC PIGMENTATION • Laugier – hunziker pigmentation DEPIGMENTATION • Vitiligo HAEMOGLOBIN & IRON ASSOCIATED PIGMENTATION • Ecchymosis • Purpura / Petechiae • Hemochromatosis
  • 9.
  • 10. Classification Dr. Reshna Roy. Classification of oral pigmented lesions: A review .International Journal of Applied Dental Sciences 2019; 5(2): 397-402
  • 11. MISCELLANOUS LESIONS THAT MAY BE ASSOCIATED WITH ORAL MUCOSAL DISCOLORATION
  • 12. Investigations • Biopsy • Diascopy • Radiography • Blood tests
  • 13.
  • 15. Freckle / ephelis • commonly occuring, asymptomatic , small (1–3mm), well circumsribed , tan or brown colored macule • SITE- sun exposed regions of facial & perioral skin. • ETIOLOGY- overproduction of direct melanocyte • Polymorphisms in MC1R gene is strongly associated with development of childhood freckles.
  • 16. Oral / labial melanotic macule • Etiology – trauma (Increase in melanin synthesis by melanocytes without an increase in the number of melanocytes) • GENDER- females, any age • SITE- lower lip & gingiva. • Clinical features- Melanotic macules tend to be small (<1cm), well circumscribed , oval or irregular in outline & often uniformly pigmented.
  • 17. Oral melanoacanthoma • Etiology - acute trauma or a history of chronic irritation • Proliferation of dendritic melanocyte scattered throughout thickness of an acanthotic and hyperkeratotic surface epithelium • Features- Rapidly enlarging , ill defined , macular or plaque like lesion, Dark brown to black, flat or raised • Site- Buccal mucosa most common site of occurrence • Treatment is source of irritation should be removed
  • 18. Melanocytic nevus • Etiology  Effect of sun exposure recognized in development of cutaneous nevi.  Recent study shows dermal melanocytic nevi exhibit somatic activating mutations in BRAF oncogene. • Features- asymptomatic, small (1cm) , solitary , brown or blue , well circumscribed nodule or macule. • Site - Oral nevi present in hard palate is the most common site , followed by buccal & labial mucosa & gingiva. • Treatment - complete but conservative surgical excision. • Rare recurrence
  • 19. Malignant melanoma • Etiology  Episodes of acute sun exposure , especially at young age  Immunosuppresion  Exhibit mutation in the BRAF , HRAS & NRAS proto oncogenes. • Site- Palate represents most common site & next comes the maxillary gingiva. • Features- macular , plague like or mass forming , well circumscribed, irregular & exhibit focal or diffuse areas of brown , blue or black pigmentation. • Radial growth phase and vertical growth phase • ABCDE of melanoma  A- asymmetry  B- border irregular  C- color irregularity  D- diameter >6mm  E- evolving over time
  • 20. Malignant melanoma • Types – • 1. superficial spreading melanoma (65%) • 2. nodular melanoma (13%) • 3. lentigo maligna melanoma (10%) • 4. acral lentiginous melanomas (10%) • 5. mucosal lentiginous melanomas (3%) • Treatment is ablative surgery with wide margins . • Adjuvant radiotherapy is necessary. • Recent development is antitumor vaccine adjuvant interferon alpha – 2B therapy is used to treat primary cutaneous melanomas >2mm in thickness.
  • 21. Multifocal / diffuse pigmentation
  • 22. Physiologic pigmentation • More common • Mostly occur in gingiva • Treatment is gingivectomy & laser therapy have been used to remove pigmented oral mucosa. • Effects of treatment is temporary & may eventually recur.
  • 23. Drug induced melanosis • Chief drugs include a) Minocycline – tetracycline derivative b) Antimalarials include chloroquine, quinacrine hydroxychloroquine, c) Phenothiazines such as chlorpromazine d) Oral contraceptives e) Cytotoxic medications such as cyclophosphamide • Clinically the pigment can be diffuse yet localised to one mucosal surface , often hard palate • Lesions are flat & without any evidence of nodularity or swelling. • Diagnosis & treatment is discoloration tends to fade within a few months after the drug is discontinued.
  • 24. Smokers melanosis • Features- Diffuse melanosis of anterior facial maxillary & mandibular gingivae , buccal mucosa , lateral tongue , palate & floor of mouth • Pigmented areas are brown , flat & irregular. • Etiology- Melanin synthesis is stimulated by tobacco smoke products. • Heat of smoke may stimulate pigmentation.
  • 25. Post inflammatory pigmentation • Focal or diffuse pigmentation in areas that were subjected to previous injury or inflammation. • The mucosa overlying a non melanocytic malignancy may become pigmented.
  • 26. Melasma / chloasma • Acquired symmetric melanosis that typically develops on sun exposed areas of skin & frequently on face. • Forehead, cheeks, upper lips & chin are most commonly affected areas. • Melasma has been used to describe any form of generalised facial hyperpigmentation including those related to post inflammatory changes & medication use.
  • 28. Hypoadrenocorticism • As steroid levels decrease , there is a compensatory activity by ACTH secretion , but if persists , the serum levels of alpha melanocyte stimulating hormone also increase. • Mucocutaneous hyperpigmentation • Generalised bronzing of skin & diffuse but patchy melanosis of oral mucosa. • Treatment is exogenous steroid replacement therapy.
  • 29. Cushing's syndrome • Prolonged exposure of endogenous or exogenous corticosteroids. • Due to activating , germline mutations in ACTH receptor. • Weight gain & characterstic “moon facies”. • Diffuse mucocutaneous pigmentation. • Treatment is surgical , radiation or medicinal therapy
  • 30. Hyperthyroidism • 40% of black patients with thyrotoxicosis may present mucocutaneous pigmentation. • Pigmentation tends to resolve following treatment of thyroid abnormality. • Melasma • Intolrence to heat, bulging of eye, facial flushing, enlarged thyroid, clubbing
  • 31. Primary biliary cirrhosis • Autoimmune • Develops in middle aged women. • Disease results from damage to small intra hepatic bile ducts. • Oral mucosal tissues are not affected • Elevated serum copper level lead to tyrosinase reaction and increase melanin synthesis
  • 32. Vitamin B12 deficiency • Generalised burning sensation & erythema & atrophy of the mucosal tissue. • Pigmentation resolves following vitamin B12 levels.
  • 33. Peutz – jeghers syndrome • Etiology- Autosomal dominant disease associated with mutations in STK11/LKB1 tumor suppressor gene. • Features- Intestinal polyposis, cancer predisposition & multiple, small, pigmented macules of lip , perioral skin , hand & feet. • Resemble ephelies usually <0.5mm in diameter. • Lesion may develop on anterior tongue , buccal & labial mucosa. • Lip & perioral pigmentation is highly distinctive
  • 34. Café –au – lait pigmentation • Identified in number of different genetic disorders include a) Neuro fibromatous type . b) Mccune– albright syndrome c) Noonans syndrome • Features - Present as tan or brown colored , irregularly shaped macules of variable size. • Occur anywhere on skin , oral macular pigmentation have been reported. • Well circumscribed, pigmented macule or patch , few mm to cms, appear at birth or early life
  • 35. HIV / AIDS • Pigmentation may be related to intake of various medications - anti fungal & anti retroviral drugs. • May also occur due to adreno cortical destruction by virulent infectious organisms. • Significant correlation between mucocutaneous pigment & CD4 counts / mili litre less than or equal to 200. • Site- Buccal mucosa is most affected site ,gingiva , palate &tongue involved
  • 36. Idiopathic pigmentation • LAUGIER – HUNZIKER PIGMENTATION: • Hyperpigmentation of oral mucosal tissues involve lips & buccal mucosa. • Pigmentation of esophageal , genital & conjunctival mucosae & acral surfaces. • Nail involvement in form of longitudinal melanotic streaks & without evidence of dystrophic change. • Multiple , discrete , irregularly shaped brown oral macules & not more than 3mm in diameter
  • 37. Treatment of mucocutaneous melanosis • Laser therapy has proven effective but recurrence occur in 20% of treated patients. • Cryotherapy • Phototherapy include intense pulsed light & fractional photothermolysis. • First- line therapy involves application of topical medicaments , that is bleaching cream. • Simple agents such as azelaic acid or hydroquinone. • Triple combination therapy a. 4% hydroquinone b. 0.05% retinoic acid c. 0.01% fluocinolone acetonide has proven effective in 90% of patients.
  • 38. Depigmentation • VITILIGO : • Relatively common , acquired autoimmune disease that is associated with hypomelanosis. • Focal areas of depigmentation • Vitiligenous lesion often present as well –circumscribed , round , oval ,or elongated pale or white colored macules that may coalesce into larger areas of diffuse pigmentation. • Arise in any patients undergoing immunotherapy • Hypomelanosis of inner & outer surfaces of lips & perioral skin may be seen in up to 20% of patients. • Treatment with topical corticosteroids , systemic photochemical therapies (psoralen & ultraviolet A exposure proven effective. • Medicinal depigmentation that is cutaneous bleaching to create unified skin color. • Surgical intervention may be only optional (autologous epithelial grafts) used succesfully
  • 40. Ecchymosis • Traumatic ecchymosis is common on the lips and face yet is uncommon in oral mucosa except in cases of blunt force trauma and oral intubation. • Immediately following traumatic event erythrocyte extravasation into the sub mucosa will appear as bright red macule. • The lesion will assume brown coloration within few days, after hemoglobin is degraded to hemosiderin.
  • 41. PURPURA/PETECHIAE • Petechiae typically characterised as being pinpoint or slightly larger than pinpoint and purpura as multiple, small 0 to 2 mm collections of extravasated blood. • Oral purpura may develop as a consequence of trauma or viral or systemic disease, identified in soft palate although any mucosal site may be affected.
  • 42. HEMOCHROMATOSIS • Chronic, progressive disease that is characterized by excessive iron deposits (usually in the form of hemosiderin) in the liver and other organs and tissues. • Oral mucosal pigmentation is also well reorganized. • Oral pigmentation is often diffuse and brown to gray in appearance. • Palate and gingiva are most commonly affected.
  • 44.
  • 45. AMALGAM TATTO: • Etiology is deposition of amalgam material into submucosal tissue. • Lesions small, asymptomatic, macular and bluish gray or oven black in appearance. • Gingiva, alveolar mucosa, buccal mucosa and floor of mouth are most common sites. • Lesions found in vicinity of teeth with large amalgam restoration or crowned teeth and also in around healed extraction sites.
  • 46. GRAPHITE TATTOO • Site- Commonly seen on palate • Etiology- Represent traumatic implantation of graphite particles from a pencil • Feature- Lesion present similar to amalgam tattoo. Diffuse macular lesion • So biopsy is often warranted.
  • 47. ORNAMENTAL TATTOOS • South African female tribal custom includes brushing the teeth and gums with a chewed root of the tree with the belief that promotes oral health. • Plant root contain napthoquinones are pigmented and the mouths of root users are typically bright orange.
  • 48. MEDICINAL METAL INDUCED PIGMENTATION • Silver may cause generalized blue- gray discoloration (argyria). • Gold induced pigment may appear blue-gray or purple (chrysiasis). • Generalized black pigmentation of tongue due to chewing of bismuth sub salicylate tablets, a commonly used antacid.
  • 49. HEAVY METAL PIGMENTATION • Lead, mercury, bismuth and arsenic have shown to be deposited in oral tissue if ingested in sufficient quantities over a extended period of time. • Found along the free marginal gingiva, metallic line usually gray-black appearance. • Signs and symptoms of metal poisoning- neurologic disorders, intestinal pain and sialorrhea.
  • 50. HAIRY TONGUE • Change in oral flora associated with chronic antibiotic therapy. • Colonization of chromogenic bacteria impart variety of colors white, green, brown or black. • Various foods, drinks and also smoking of tobacco or crack cocaine has been shown in black hairy tongue. • Treatment is using tongue scrapper and limit ingestion of coloring foods.
  • 51. HEMANGIOMA • Lesions presenting as proliferation of endothelial cells that line vascular channels • Arise in childhood, adults • Child- skin, scalp, within connective tissue of mucous membrane • Approx 85% of childhood, onset spontaneous regress after puberty • Appear as reddish blue or deep blue • Mostly are raised and nodular, some may be flat, macular, diffuse, particularly on facial skin – port wine stain • Oral hemangioma- tongue, lip
  • 52. • Concurrent history of seizures, • RADIOGRAPH – vessel wall calcifications – TRAM LINE CALCIFICATIONS • Honey comb trabeculated appearance • Overlying cortex is expanded and thinned but complete cortical disruption and invasion into soft tissue are not present • TREATMENT- • Sclerosing agent- 1% sodium tetradecyl sulfate (intrlesional)- 0.05- 0.15ml/cm3 • Laser, cryosurgery
  • 53.
  • 54. VARIX • Pathologic dilatations of veins or venules are varices or varicosities • Site- ventral tongue- tortuous ,serpentine blue, red, and purple elevations • Progressively prominent with age • painless & non haemorrhagic • No interference with mastication
  • 55. ANGIOSARCOMA  Malignant vascular neoplasm.  Arise anywhere in body- head and neck, breast and extremities,  Male , any age  Colour: red ,blue or purple .  Very aggressive and rare type of soft tissue sarcomas  can arise from blood or lymph vessel endothelial cells / pericytic cells of vasculature.  Treated by radical excision
  • 56. KAPOSI SARCOMA • Tumor of endothelial cell origin • HHV-8 • 2 forms- elderly men ( oral mucosa & skin of lower extremities) , children in equatorial africa ( lymph nodes)-aggressive & lethal • Slow progressive, less metastasis • Oral tumors - red, blue, and purple-hard palate, facial gingiva
  • 57. Differential diagnosis of a case of brownish black pigmentation
  • 58. Differential diagnosis of a case of blue to purplish pigmentation
  • 59. How to approach a case of tooth staining HISTORY Provides useful information regarding etiology Includes: • Dental history (mouthwash, fluoride inatake, oral hygiene practice) • Medical history (childhood disease, medications) • Family history (genetic disease- amelogenesis imperfecta) • Diet history (nutritional deficiency, diet) • Social history (occupational, use of tobacco)
  • 60. CLINICAL EXAMINATION Inspection • Teeth staining unusual and generalized • Found on surfaces with poor tooth brush accessibility • No signs of pulpal involvement • Intrinsic – either generalized or localized Scratch test • Distinguish between intrinsic and extrinsic staining • Discolored tooth surface scratched • Intrinsic stains donot get removed Radiography • Useful in intrinsic staining (amelogenesis imperfecta, internal resorption)